23 May 2013
Keywords: Mylan, Generic Lipitor, Atorvastatin, Europe, Financial guidance, Share buy-back
Article | 14 May 2012
US generic drug major Mylan’s (Nasdaq: MYL) shares 2.2% to $21.55 in morning last Friday after the company revealed that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 May 2012
© 2013 thepharmaletter.com